Drugs / Ad-E6E7
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03618953 Background | Jun 2018 → Mar 2021 | virus associated tumor | Turnstone Biologics, Corp. | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ad-E6E7 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03618953 ↗ |
| Modality | Vaccine | “Adenovirus vaccine” NCT03618953 ↗ |
| Route | Intramuscular | “Ad-E6E7 administered IM on study Day 1” NCT03618953 ↗ |